Survival estimates and CIR of the whole patient population. With a median follow-up of 28.8 months, 2-year-OS (A) and DFS (B) were 56% (median duration 38 months) and 54% (median duration 32.4 months), respectively. (C) CIR, considering death in CR as a competing risk, was 33%.